Makers Laboratories Ltd

Makers Laboratories Ltd. will close its trading window for insider trading purposes starting October 1, 2026, and continuing until 48 hours after the declaration of the company’s unaudited financial results for the second quarter and half-year ended September 30, 2026, of the financial year 2026-27, according to a filing with the BSE Ltd.

Makers Laboratories Ltd announced via online filing to the BSE Limited on September 1, 2026, that CARE Edge Ratings has reaffirmed the company’s long term bank facilities with a rating of CARE BBB+; Stable, pertaining to long term bank facilities amounting to Rs 8.00 crore; this reaffirmation represents no enhancement, assignment, or withdrawal of ratings, and applies solely to the aforementioned Rs 8.00 crore of long term bank facilities.

Makers Laboratories Ltd share price gained 1.62% to Rs 165.9 after the company's net profit saw a strong growth of 29.21% to Rs 4.6 crore, while revenue from operations increased 19.64% to Rs 42.77 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 24.84 lakh crore, gaining 5.32%. It has improved by 0.53% over last one week and moving up by 11.64% in last one month while the market capitalization of Makers Laboratories Ltd has edged up by 11.30% and 5.84% in the same period respectively. Profit before tax (PBT) of Makers Laboratories Ltd stood at Rs 6.29 crore in Q2 FY26, surging by 217.68% year-on-year, and expanding by 32.98% quarter-on-quarter. EBITDA came in at Rs 6 crore, rallying 131.75% YoY and jumping 40.80% sequentially. Total expenses increased by 16.86% to Rs 36.94 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 15.02 crore, soaring by 36.79% YoY, while employee benefits expense was at Rs 4.08 crore, ticking higher by 4.35% YoY. For the TTM ended FY26, revenue from operations improved 16.43% to Rs 140.59 crore, while net profit tanked by 27.96% to Rs 7.86 crore, compared to previous TTM. EBITDA saw a sharp decline of 476% to Rs 13.03 crore, and PBT declined 16.85% to Rs 11.15 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 14.29 crore in FY26, as against Rs 4.08 crore in FY25. Makers Laboratories Ltd surged by 12.02% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 1.97% during the same period.

Makers Laboratories will hold a meeting of the Board of Directors of the Company on 7 August 2026.

Makers Laboratories announced that the 41th Annual General Meeting(AGM) of the company will be held on 7 August 2026.

Net profit of Makers Laboratories reported to Rs 1.09 crore in the quarter ended March 2026 as against net loss of Rs 0.05 crore during the previous quarter ended March 2025. Sales rose 5.46% to Rs 35.75 crore in the quarter ended March 2026 as against Rs 33.90 crore during the previous quarter ended March 2025. For the full year,net profit declined 68.62% to Rs 2.35 crore in the year ended March 2026 as against Rs 7.49 crore during the previous year ended March 2025. Sales rose 16.43% to Rs 140.59 crore in the year ended March 2026 as against Rs 120.75 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales35.7533.90 5 140.59120.75 16 OPM %14.749.12 -10.486.94 - PBDT5.873.03 94 15.688.89 76 PBT4.732.13 122 11.154.10 172 NP1.09-0.05 LP 2.357.49 -69 Powered by Capital Market - Live

Makers Laboratories will hold a meeting of the Board of Directors of the Company on 26 May 2026.

Net profit of Makers Laboratories reported to Rs 0.94 crore in the quarter ended December 2025 as against net loss of Rs 0.30 crore during the previous quarter ended December 2024. Sales rose 28.82% to Rs 35.67 crore in the quarter ended December 2025 as against Rs 27.69 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales35.6727.69 29 OPM %11.664.73 - PBDT4.291.99 116 PBT3.150.68 363 NP0.94-0.30 LP Powered by Capital Market - Live

Makers Laboratories will hold a meeting of the Board of Directors of the Company on 10 February 2026.Powered by Capital Market - Live

Net loss of Makers Laboratories reported to Rs 0.12 crore in the quarter ended September 2025 as against net profit of Rs 8.82 crore during the previous quarter ended September 2024. Sales rose 15.56% to Rs 34.17 crore in the quarter ended September 2025 as against Rs 29.57 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales34.1729.57 16 OPM %6.677.37 - PBDT2.4212.27 -80 PBT1.2910.97 -88 NP-0.128.82 PL Powered by Capital Market - Live